NewsRoom Articles - Page 26 of 153 - PsychedelicNewsWire (PNW)

MondayJul 24, 2023 1:30 pm

New Research Suggests Psychedelic Helplines Could Avert Possible Harms

New research analyzing psychedelic use in nonclinical settings has found that creating psychedelic helplines could help alleviate the potential harms of recreational psychedelic use. Researchers behind the recent study were concerned with the lack of safety protocols for psychedelic use in nonclinical settings as recreational psychedelic use is on the rise among Americans. Psychedelics have captured the scientific community and the mainstream public’s attention due to their potential mental health benefits. A growing body of research has revealed that psychedelics can treat a myriad of mental health conditions with few side effects and offer long-term relief to patients who didn’t…

FridayJul 21, 2023 1:17 pm

Study Suggests Psychedelic Microdosing Could Heighten Authenticity

Research into psychedelics is increasingly revealing that these purportedly dangerous drugs may have potent mental health benefits. While modern antidepressants work by influencing the levels of hormones such as serotonin in the brain, psychedelics seem to deliver their benefits by influencing the mind and perception. Their unique effects allow psychedelics to deliver long-term benefits against a myriad of mental disorders, with minimal side effects. Clinical studies have found that psychedelics, including psilocybin, can treat conditions such as major depressive disorder when conventional treatments have failed. A recent study looking at the potential benefits and risks of microdosing psychedelics has found…

ThursdayJul 20, 2023 2:53 pm

UC Berkeley Survey Finds Psychedelics Use Evolving

A recent survey by the Center for the Sciences of Psychedelics (BCSP) at UC Berkeley has found that the way people use psychedelics is evolving amid increased awareness and local legislative reform. Americans are more aware of psychedelics than they have been for decades, and the poll found that most survey respondents support regulating psychedelic-assisted therapies or at least decriminalizing psychedelics. As with cannabis, psychedelics have benefitted from a nationwide wave of reform that has seen legislators in several states table proposals to legalize therapeutic psychedelic use. In addition, psychedelics have seen a significant surge in interest from the scientific…

WednesdayJul 19, 2023 3:17 pm

Study Documents How People on Psilocybin vs. Antidepressants Process Emotions

A new study has attempted to explore how people on antidepressants such as Lexapro (escitalopram) and psilocybin process emotions on a neural level. The researchers behind the recent study wanted to analyze how people process their emotions when under the influence of psilocybin compared with Lexapro, a selective serotonin reuptake inhibitor (SSRI) that is commonly used as an antidepressant. Depression is the largest cause of disability across the globe, affecting tens of millions of people and costing adults in the United States more than $200 billion in 2018. While some people have greatly benefitted from current therapies, these treatments are…

TuesdayJul 18, 2023 3:38 pm

Moms Are Microdosing Psychedelics to Get Through Hectic Days

It seems that an increasing number of mothers in the United States are microdosing psychedelics to help them cope with the stresses of motherhood. As a growing body of research indicates that psychedelics may be effective mental-health treatments, the trend of microdosing psychedelics, specifically among moms, has been on the rise. These studies may be the first official efforts to fully research psychedelics and their potential benefits, but they have been incredibly encouraging so far, indicating that hallucinogenics could help treat various mental health conditions that typically don’t react to conventional medications. Microdosing psychedelics means taking small amounts of hallucinogens,…

MondayJul 17, 2023 3:48 pm

Massachusetts Campaigners File Paperwork to Put Psychedelics on Ballot

The Massachusetts for Mental Health Options (MMHO) committee recently kicked off efforts to add a psychedelics legalization measure on next year’s ballot. The recently formed committee has filed paperwork to put a measure that would legalize therapeutic psychedelic use in front of voters in November 2024. With legislators, reform activists and mental-health professionals pushing for the legalization of therapeutic psychedelics, Massachusetts isn’t the first state to consider legalizing hallucinogenics, and it likely won’t be the last. Several states are considering legalizing psychedelics amid a national mental-health crisis that has left millions of Americans grappling with conditions such as depression with…

FridayJul 14, 2023 12:16 pm

Study Shows Psilocybin Therapy Could Be Easier on the Pocketbook

A recent study by leading psychedelic academics has found that psilocybin-assisted therapy for depression could be more affordable compared to conventional treatments. Psilocybin is the main hallucinogenic agent in magic mushrooms, and as with several other psychedelics, it has been subject to increased scientific research in recent years. These scientific studies have found that psychedelics can offer relief against a plethora of mental health conditions, with psilocybin exhibiting significant potential against treatment-resistant depression. Research has found that psilocybin can also treat other mental health disorders such as obsessive-compulsive disorder and enhance positive psychological states such as optimism, happiness and satisfaction.…

ThursdayJul 13, 2023 1:38 pm

Group Psychotherapy Coupled with Psilocybin Shows Promise for Cancer Patients

A recent study has found that psilocybin-assisted group psychotherapy can help alleviate the mental woes of cancer patients with depression. While several treatments are designed to kill cancer cells and alleviate the physical symptoms caused by cancer, the mental distress associated with a cancer diagnosis and treatment is rarely addressed. Research shows that around 25% of people diagnosed with cancer suffer from depression. Cancer patients also deal with emotions such as anxiety, fear, sadness and grief, especially if they are diagnosed with particularly aggressive cancers. These psychological symptoms can cause cancer patients to become fatigued, withdrawn, lose interest in their…

WednesdayJul 12, 2023 12:30 pm

Experts Weigh in on FDA’s Draft Psychedelics Research Guidelines

For the past several years, a flurry of psychedelic-related research has found that hallucinogenic drugs have various applications in the mental health field. Researchers have found that pairing talk therapy with psychedelics is incredibly effective at alleviating conditions such as depression, anxiety and post-traumatic stress disorder. Several years after psychedelics began gaining steam as alternative mental health treatments, the U.S. Food and Drugs Administration has finally issued guidance on the management of psychedelic clinical trials. Even though initial results have been incredibly encouraging, significantly more research and clinical trials are needed before psychedelic-based treatments are developed and deployed to the…

TuesdayJul 11, 2023 2:43 pm

Bipartisan Legislators Welcome FDA Decision to Publish Psychedelics Research Guidelines

Bipartisan congressional legislators are pleased with recent actions by the U.S. Food and Drug Administration (FDA) regarding psychedelic policy and research. Only a few days after the lawmakers filed a bill requesting that the agency craft measures to guide psychedelic research in the United States, the FDA published the country’s first draft guidance on psychedelic research. Released in late June, the draft stated that psychedelics showed “initial promise” as potential therapies and outlined “unique” considerations for researchers to note during their research. The 14-page document provides America’s first-ever framework for psychedelic research and could aid in the eventual development of…

News and publishing service for psychedelic related companies

Contact us: 512.354.7000